10月20日，联合健康盘中上涨3.14%，报419.66美元，成交额9.54亿美元。
消息面上，RBC将联合健康目标价由478美元上调至498美元，并维持跑赢大市评级，成为当日股价异动的直接催化。
此前公司第三季度调整后每股收益4.69美元、营收1126.9亿美元，均高于市场预期，并将全年调整后每股收益指引上调至至少20.50美元。尽管近期亦有机构下调目标价，但最新上调目标价叠加财报后盈利预期改善，强化了市场对其基本面修复的判断。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.